org placeholder image

Saba Malak

Chief Executive Officer, Chairman at Cytimmune Sciences

  • LinkedIn

Email Email: s****@putnam.com

phone noPhone Number: (***)-***-****

Cytimmune is a solid tumor platform company. Our lead asset is Phase 2-ready and partnered with the US National Cancer Institute. Our pipeline is comprised of cytokine-based combination t...

Read More

map
CYTIMMUNE SCIENCES

CYTIMMUNE SCIENCES

  • description Description
    CytImmune is a biotechnology company that has invented, patented, and developed a set of novel technologies with the potential to treat up to 85% of all cancers. Our IO+ platform turns hot tu...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Cytimmune Sciences Org Chart and Mapping

Saba Malak

Chief Executive Officer, Chairman

Frequently Asked Questions Regarding Saba Malak

Answer: Saba Malak works for Cytimmune Sciences as Chief Executive Officer, Chairman

Answer: Saba Malak’s role in Cytimmune Sciences is Chief Executive Officer, Chairman

Answer: Saba Malak's email address is s***@gmail.com

Answer: Saba Malak's business email address is s****@putnam.com

Answer: Saba Malak’s direct phone number is (***)-***-****

Answer: Saba Malak works in the industry of: Biotechnology

Answer: Saba Malak is the current Chief Executive Officer, Chairman at Cytimmune Sciences.... Read More

Answer: Saba Malak works Cytimmune Sciences located at Broschart Rd, Rockville, , 20850, Maryland, 15010, United States

Answer: Cytimmune Sciences's Chief Executive Officer, Chairman is Saba Malak

Answer: Saba Malak contact details:

  • Phone number  :  (***)-***-****
  • Email  :  s****@putnam.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access